Details for New Drug Application (NDA): 210243
✉ Email this page to a colleague
The generic ingredient in RANITIDINE HYDROCHLORIDE is ranitidine hydrochloride. There are forty-three drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the ranitidine hydrochloride profile page.
Summary for 210243
Tradename: | RANITIDINE HYDROCHLORIDE |
Applicant: | Granules |
Ingredient: | ranitidine hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 210243
Mechanism of Action | Histamine H2 Receptor Antagonists |
Suppliers and Packaging for NDA: 210243
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
RANITIDINE HYDROCHLORIDE | ranitidine hydrochloride | TABLET;ORAL | 210243 | ANDA | Granules India Ltd | 62207-773 | 62207-773-36 | 5 BAG in 1 CARTON (62207-773-36) / 10000 TABLET in 1 BAG (62207-773-32) |
RANITIDINE HYDROCHLORIDE | ranitidine hydrochloride | TABLET;ORAL | 210243 | ANDA | Granules India Ltd | 62207-773 | 62207-773-41 | 1 BOTTLE in 1 CARTON (62207-773-41) / 24 TABLET in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 150MG BASE | ||||
Approval Date: | Aug 20, 2018 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 150MG BASE | ||||
Approval Date: | Aug 20, 2018 | TE: | RLD: | No |
Complete Access Available with Subscription